- Trials with a EudraCT protocol (44,358)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (18,700)
44,358 result(s) found.
Displaying page 975 of 2,218.
| EudraCT Number: 2006-000073-29 | Sponsor Protocol Number: MRZ 60201-0528/1 | Start Date*: 2006-07-10 | |||||||||||
| Sponsor Name:Merz Pharmaceuticals GmbH | |||||||||||||
| Full Title: Prospective, randomised, double-blind, placebo-controlled multicentre pilot trial to investigate the impact of an early use of NT 201 in patients with an acute cerebrovascular event on the developm... | |||||||||||||
| Medical condition: Patients with acute cerebrovascular event showing signs of beginning upper limb spasticity | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2005-004350-28 | Sponsor Protocol Number: VEG20007 | Start Date*: 2006-08-22 |
| Sponsor Name:GlaxoSmithKline Research & Development Limited | ||
| Full Title: A Phase II, Open-Label, Randomized, Multicenter Trial of GW786034 (Pazopanib) in Combination with Lapatinib (GW572016) Compared to Lapatinib Alone as First Line Therapy in Subjects with Advanced or... | ||
| Medical condition: Advanced or metastatic breast cancer with ErbB2 FISH postive tumours | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Female | |
| Trial protocol: GB (Completed) HU (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-005115-16 | Sponsor Protocol Number: SU-011248 | Start Date*: 2006-05-05 |
| Sponsor Name:Joaquim Bellmunt Molins | ||
| Full Title: A phase ii study assesing su-011248 in previously untreated patients with advanced urothelial cancer ineligible for cisplatin-based chemotherapy Estudio fase II que evalúa la eficacia y tolerabilid... | ||
| Medical condition: Previously untreated patients with advanced urothelial cancer ineligible for cisplatin-based chemotherapy | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2005-004889-17 | Sponsor Protocol Number: MAD 105516 | Start Date*: 2006-05-23 |
| Sponsor Name:GlaxoSmithKline Research and Development Limited | ||
| Full Title: A randomized, double-blind, placebo-controlled, crossover study to evaluate the effects of morning administration of GW679769 (10mg and 30 mg) on polysomnograph sleep recordings, subjective sleep a... | ||
| Medical condition: Primary insomnia | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-005313-38 | Sponsor Protocol Number: SOP-386-NEU-005313-38 | Start Date*: 2006-07-17 |
| Sponsor Name:Klinikum rechts der Isar, Technical University of Munich | ||
| Full Title: Somatostatin_octretide for prevention of rebleeding from gastrointestinal angiodysplasias | ||
| Medical condition: study to investigate the efficacy of Octeoid LAR plus standard therapy versus standard therapy alone in patients with bleeding gastrointestinal angiodysplasias | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-003196-21 | Sponsor Protocol Number: SE 03 | Start Date*: 2008-01-22 |
| Sponsor Name:Technische Universität München | ||
| Full Title: Enhancing the Therapeutic Efficacy of Sleep Deprivation by Modafinil - a double blind, randomized, placebo-controlled, monocentric phase II study | ||
| Medical condition: Inpatients of the Psychiatric Hospital of the Technical University of Munich Diagnoses: - Depressive episode with somatic symptoms (ICD-10: F32.01, F32.11, F32.21) - Recurrent depressive disorder... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2006-000574-69 | Sponsor Protocol Number: D9612L00076 | Start Date*: 2006-04-07 |
| Sponsor Name:AstraZeneca A/S | ||
| Full Title: Development of an algorithm for identification of responders to short term treatment with esomeprazol (Nexium) in primary care. | ||
| Medical condition: acid related disease | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: DK (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2006-001965-41 | Sponsor Protocol Number: BRD/06/052 | Start Date*: 2008-09-05 |
| Sponsor Name:University College London | ||
| Full Title: Phase III, multicentre, randomised study of fludarabine/cyclophosphamide combination with or without Rituximab in patients with untreated mantle cell lymphoma | ||
| Medical condition: Mantle Cell Lymphoma | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2004-002783-24 | Sponsor Protocol Number: MEC02/007 PREDICT | Start Date*: 2006-05-25 |
| Sponsor Name:AMC Medical research BV | ||
| Full Title: Prednisolone versus Dexamethasone in Chronic inflammatory demyelinating polyradiculoneuropathy Trial; PREDICT-trial | ||
| Medical condition: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an immune-mediated disorder. CIDP is characterised by motor and/or sensory symptoms and signs in more than one limb, developing o... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2005-005345-19 | Sponsor Protocol Number: R076477BIM3003 | Start Date*: 2006-05-25 |
| Sponsor Name:Janssen-Cilag International N.V. | ||
| Full Title: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Flexibly-Dosed Extended-Release Paliperidone as Adjunctive Therapy to Mood S... | ||
| Medical condition: Bipolar I Disorder | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: EE (Completed) BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2006-001902-10 | Sponsor Protocol Number: 2006/168 | Start Date*: 2006-05-31 |
| Sponsor Name:Kirurgisk Forskningsafsnit, Herning Sygehus | ||
| Full Title: Effects of caffeine on people suffering from intermittens claudication. Three double blinded, placebo-controlled cross-over studies and a follow-up study. | ||
| Medical condition: Intermittens claudication, peripheral arterial disease (PAD) Atherosclerotic disease of the lower extremities | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DK (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2006-001522-84 | Sponsor Protocol Number: V72P6 | Start Date*: 2006-08-29 |
| Sponsor Name:Novartis Vaccines and Diagnostics Srl. | ||
| Full Title: A Phase 2, Open Label, Multi-Center, Controlled, Randomized Study of the Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine +/- OMV, when Administered to Health... | ||
| Medical condition: The Novartis Meningococcal B recombinant vaccine is intended for prevention of meningitis and/or septicemia caused by Neisseria meningitidis serogroup B. The objective of the Novartis Meningococcal... | ||
| Disease: | ||
| Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-006026-28 | Sponsor Protocol Number: A3481066 | Start Date*: 2006-09-25 | |||||||||||
| Sponsor Name:Pfizer Pharma GmbH | |||||||||||||
| Full Title: Randomized, Double-Blind Study of the morphine-sparing efficacy and safety of Parecoxib sodium 40 mg i.v. followed by 20 mg i.v. every 12 hours in the treatment of pain following radical prostatectomy | |||||||||||||
| Medical condition: Patients who are scheduled to undergo routine radical prostatectomy performed under a standardized regimen of general anesthesia, and who are expected to experience moderate to severe postsurgical ... | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male | ||||||||||||
| Trial protocol: DE (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2006-002500-34 | Sponsor Protocol Number: ROPP-2005-01 | Start Date*: 2006-08-31 |
| Sponsor Name:Ann Hellström | ||
| Full Title: A Phase I, Open-Label, Pharmacokinetic, Single-Center, Dose Evaluation Study to Determine the Dose of rhIGF-I/rhIGFBP-3 required to Increase Serum IGF-I levels to Physiological Levels in Premature ... | ||
| Medical condition: Premature male/female infants, between 26 weeks ±0 days and 29 weeks +6 days at birth, in risk of developing ROP, retinopathy of prematurity. | ||
| Disease: | ||
| Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | |
| Trial protocol: SE (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2006-002214-35 | Sponsor Protocol Number: BY9010/CP-038 | Start Date*: 2006-08-01 |
| Sponsor Name:ALTANA Pharma AG | ||
| Full Title: Free, not protein-bound concentrations of budesonide in subcutaneous adipose tissue, muscle tissue, and serum after oral inhalation via Turbohaler® | ||
| Medical condition: Phase I healthy volunteer study | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2006-002938-38 | Sponsor Protocol Number: MHH – EPONTX – 01/06 | Start Date*: 2006-11-17 |
| Sponsor Name:Hannover Medical School | ||
| Full Title: EFFECT OF ERYTHROPOIETIN ON RENAL FUNCTION AFTER KIDNEY TRANSPLANTATION | ||
| Medical condition: We will investigate the effect of recombinant human erythropoietin (rHuEPO) on ischemia-reperfusion injury in patients with terminal renal failure undergoing cadaveric kidney transplantation. In th... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-000480-25 | Sponsor Protocol Number: ROCAC | Start Date*: 2006-08-24 | |||||||||||
| Sponsor Name:Investigator Trondheim Hudlegesenter AS | |||||||||||||
| Full Title: Classification and characterization of patient suffering from moderate to severe plaque psoriasis responding to subcutaneous administered efalizumab | |||||||||||||
| Medical condition: Plaque psoriasis | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: FI (Prematurely Ended) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2004-002930-21 | Sponsor Protocol Number: P03418 | Start Date*: 2006-11-01 | |||||||||||
| Sponsor Name:Schering-Plough Research Institute | |||||||||||||
| Full Title: Comparative Study of the Effect of Two Doses of Mometasone Furoate Dry Powder Inhaler 200 mcg and 400 mcg QD PM, Fluticasone Propionate 250 mcg BID, and Montelukast 10 mg QD PM, on Bone Mineral Den... | |||||||||||||
| Medical condition: Asthma | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: CZ (Completed) DK (Completed) EE (Completed) LT (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2006-003737-33 | Sponsor Protocol Number: 2006-07 | Start Date*: 2006-10-05 |
| Sponsor Name:Örebro University Hospital | ||
| Full Title: Continuous Intraperitoneal Infusion of Local Anesthetics vs. Patient Controlled Intraperitoneal injection for Postoperative Pain relief following Abdominal Hysterectomy. A randomized, double-blind ... | ||
| Medical condition: Postoperative pain after open abdominal hysterectomy | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: SE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2006-004374-27 | Sponsor Protocol Number: ProPATIent | Start Date*: 2006-10-12 |
| Sponsor Name:Philipps-University | ||
| Full Title: Prospective, randomized, doubleblind, placebo-controlled trial on changes in acetylcholine receptor antibody titres in autoimmune myasthenia gravis after influenza vaccination (ProPATIent) | ||
| Medical condition: Generalized Myasthenia gravis with positive antibodies against Acetylcholine-receptors (ICD10GM2006 G70.0) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Prematurely Ended) | ||
| Trial results: View results | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
